Cigna (CI) is positioned for durable shareholder value thanks to robust expansion in its Evernorth Health Services division and a strategic push into pharmacy benefit management. In the last fiscal year, Evernorth revenue climbed 12% to $50.4 billion, driven by a 15% increase in utilization of virtual care and health coaching. The company also added roughly 1.2 million new pharmacy members through partnerships with regional health systems, contributing to a 9% rise in pharmacy services revenue. At a forward P/E ratio of 15.2x—below the industry average of 18.7x—Cigna’s shares trade at a valuation discount that reflects conservative estimates for mid-cycle earnings. Management has committed $3 billion to share repurchases over the next 12 months and maintains a dividend yield of 1.8%, underscoring its focus on returning capital while funding continued investments in digital platforms and network expansion.